{"id":881,"date":"2025-01-17T18:37:53","date_gmt":"2025-01-17T18:37:53","guid":{"rendered":"https:\/\/pulse1study.com\/?page_id=881"},"modified":"2025-03-04T01:50:01","modified_gmt":"2025-03-04T01:50:01","slug":"pulse-1","status":"publish","type":"page","link":"https:\/\/pulse1study.com\/fr\/pulse-1\/","title":{"rendered":"Impulsion-1"},"content":{"rendered":"
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n

\nHelp shape the future of high cholesterol treatment\n<\/h1>
\nBe part of the Pulse-1 study\n<\/div>
\nThe Pulse-1 study will help determine if a single dose of an investigational medicine, called VERVE-201, can safely reduce low-density lipoprotein cholesterol (LDL-C), often referred to as \u2018bad\u2019 cholesterol, in people whose LDL-C remains too high even after taking currently available medicines.

If you have LDL-C levels that remain too high, you may be eligible to take part in the Pulse-1 study.\n<\/div>
\n \n \n \n \n \n \n \n \n \n\n \n \n \n \n \n \n\n \n Go to prescreener<\/span>\n\n \n \n <\/a>\n\n \n\n\n<\/div>
\n \n \n \n \n \n \n \n \n \n\n \n \n \n \n \n \n\n \n Go to prescreener<\/span>\n\n \n \n <\/a>\n\n \n\n\n<\/div>\n<\/div>
\n \n \n\t\n\n\n\n
\n
\n\t
\n\t\t
\"Group<\/div>\n\t<\/div><\/figure>\n\n<\/div>\n<\/div><\/div><\/div>\n<\/section>
\n \n \n\t\n\n\n\n
\n \n \n \n\t\n\n\n\n
\n\n\n \n \n